FDA
approval
· 2023-07-20
FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
Summary
FDA approved a supplemental application for Dexmethylphenidate hydrochloride from Nivagen Pharmaceuticals, Inc., relating to an approved generic product (ANDA 2…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DEXMETHYLPHENIDATE HYDROCHLORIDE (DEXMETHYLPHENIDATE HYDROCHLORIDE)